Teladoc Health Inc (TDOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -55,285 | -29,603 | -98,864 | -79,820 | -59,474 |
Depreciation Amortization | 39,231 | 18,087 | 70,390 | 53,282 | 34,790 |
Income taxes - deferred | -3,457 | -2,820 | -10,868 | -10,288 | -1,472 |
Accounts receivable | -24,773 | -17,219 | -15,884 | -12,386 | -7,237 |
Accounts payable and accrued liabilities | 1,844 | -502 | 905 | -1,976 | 374 |
Other Working Capital | -1,757 | -11,651 | -1,404 | -1,389 | -7,492 |
Other Operating Activity | 73,427 | 37,388 | 85,594 | 64,324 | 38,768 |
Operating Cash Flow | $29,230 | $-6,320 | $29,869 | $11,747 | $-1,743 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | 0 | 52,100 | 39,165 | 22,695 |
PPE Investments | -8,090 | -2,928 | -10,900 | -7,495 | -4,216 |
Net Acquisitions | -13,500 | -9,000 | -11,187 | -11,204 | N/A |
Purchase Of Investment | 0 | N/A | -5,000 | -5,000 | -5,000 |
Other Investing Activity | 0 | 0 | 0 | 0 | -11,207 |
Investing Cash Flow | $-21,590 | $-11,928 | $25,013 | $15,466 | $2,272 |
Cash Flows From Financing Activities | |||||
Debt Issued | 1,000,000 | N/A | N/A | 0 | N/A |
Debt Repayment | -228,130 | N/A | N/A | N/A | N/A |
Common Stock Issued | 35,986 | 14,889 | 36,663 | 26,695 | 17,576 |
Other Financing Activity | -19,578 | 164 | -1,569 | -1,642 | -1,676 |
Financing Cash Flow | $788,278 | $15,053 | $35,094 | $25,053 | $15,900 |
Exchange Rate Effect | -1,428 | -3,202 | 388 | -1,013 | 25 |
Beginning Cash Position | 514,353 | 514,353 | 423,989 | 423,989 | 423,989 |
End Cash Position | 1,308,843 | 507,956 | 514,353 | 475,242 | 440,443 |
Net Cash Flow | $794,490 | $-6,397 | $90,363 | $51,253 | $16,454 |
Free Cash Flow | |||||
Operating Cash Flow | 29,230 | -6,320 | 29,869 | 11,747 | -1,743 |
Capital Expenditure | -8,090 | -2,928 | -10,900 | -7,505 | -4,223 |
Free Cash Flow | 21,140 | -9,248 | 18,969 | 4,242 | -5,966 |